Outcomes of diffuse large b-cell lymphoma with MYC and/or BCL2 protein expression treated with intensive chemotherapy.

被引：0
|
作者：
Issa, Amir
Sathyanarayanan, Vishwanath
Fanale, Michelle A.
Oki, Yasuhiro
Hagemeister, Fredrick B.
Neelapu, Sattva Swarup
Nastoupil, Loretta J.
Fowler, Nathan Hale
Turturro, Francesco
Noorani, Mansoor
Ahmed, Mohamed Amin
Davis, Richard Eric
Rodriguez, Maria Alma
Wang, Michael
Feng, Lei
Young, Ken H.
McDonnell, Timothy
Pinnix, Chelsea Camille
Fayad, Luis
Westin, Jason R.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Lymphoma Myeloma, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7563
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
    Sermer, David
    Bobillo, Sabela
    Dogan, Ahmet
    Zhang, Yanming
    Seshan, Venkatraman
    Lavery, Jessica A.
    Batlevi, Connie
    Caron, Philip
    Hamilton, Audrey
    Hamlin, Paul
    Horwitz, Steven
    Joffe, Erel
    Kumar, Anita
    Matasar, Matthew
    Noy, Ariela
    Owens, Colette
    Moskowitz, Alison
    Palomba, M. Lia
    Straus, David
    von Keudell, Gottfried
    Rodriguez-Rivera, Ildefonso
    Falchi, Lorenzo
    Zelenetz, Andrew
    Yahalom, Joachim
    Younes, Anas
    BLOOD ADVANCES, 2020, 4 (14) : 3382 - 3390
  • [42] MYC/BCL2 DOUBLE EXPRESSION INCREASES A RISK OF RELAPSE OR PROGRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY M-NHL-BFM-90 PLUS RITUXIMAB
    Misyurina, A.
    Kovrigina, A.
    Baryakh, E.
    Misyurin, V.
    Kravchenko, S.
    Misyurin, A.
    Kulikov, S.
    Obukhova, T.
    Denisov, N.
    Denisova, J.
    Magomedova, A.
    Vorobiev, V.
    Mangasarova, Y.
    Gemdzhian, E.
    HAEMATOLOGICA, 2015, 100 : 399 - 400
  • [43] Co-Expression of MYC and BCL2 Protein in R-CHOP Treated De Novo Diffuse Large B-Cell Lymphoma Predicts Poor Outcome
    Slack, G. W.
    Tan, K. L.
    Scott, D. W.
    Ben-Neriah, S.
    Johnson, N. A.
    Sehn, L. H.
    Connors, J. M.
    Gascoyne, R. D.
    LABORATORY INVESTIGATION, 2012, 92 : 370A - 370A
  • [44] Co-Expression of MYC and BCL2 Protein in R-CHOP Treated De Novo Diffuse Large B-Cell Lymphoma Predicts Poor Outcome
    Slack, G. W.
    Tan, K. L.
    Scott, D. W.
    Ben-Neriah, S.
    Johnson, N. A.
    Sehn, L. H.
    Connors, J. M.
    Gascoyne, R. D.
    MODERN PATHOLOGY, 2012, 25 : 370A - 370A
  • [45] Diffuse Large B Cell Lymphoma: Role Of MYC, BCL2, BCL6 Protein Expressions and Translocations
    Sakruti, Susmita
    Bennani, Nabila
    Thota, Swapna
    Garje, Rohan
    Fawole, Adewale
    Elson, Paul
    Haddad, Abdo
    Spiro, Timothy
    Daw, Hamed
    BLOOD, 2013, 122 (21)
  • [46] CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma
    Gong, Qi-Xing
    Wang, Zhen
    Liu, Chong
    Li, Xiao
    Lu, Ting-Xun
    Liang, Jin-Hua
    Xu, Wei
    Li, Jian-Yong
    Zhang, Zhi-Hong
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (09) : 795 - 801
  • [47] The significance of concurrent MYC and BCL2 expression in Egyptian patients with diffuse large B-cell NHL
    Abdelhamid, Thoraya M.
    Gaber, Ayman A.
    Abdelfattah, Raafat M.
    Algamal, Dina A.
    Hamdy, Omar
    Mohamed, Ghada
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
  • [48] Coexpression of MYC and BCL2 Protein in Diffuse Large B-Cell Lymphoma Predicts a Poor Outcome in Patients Treated With Autologous Hematopoietic Stem Cell Transplantation
    Low, Lawrence
    Song, Joo
    Mei, Matthew
    Krishnan, Amrita
    Nademanee, Auayporn
    Popplewell, Leslie
    Chen, Robert
    Spielberger, Ricardo
    Cai, Ji-lian
    Chen, Yuan-Yuan
    Gaal, Karl
    Aoun, Patricia
    Weisenburger, Dennis
    Kim, Young
    Zumel, Sean
    MODERN PATHOLOGY, 2015, 28 : 361A - 361A
  • [49] The Impact of Concurrent Expression of MYC and BCL2 on Outcomes of Localized Primary Gastric Diffuse Large B-Cell Lymphoma Undergoing Rituximab-Containing Chemotherapy with or without Radiotherapy
    Kawajiri, Akihisa
    Maruyama, Dai
    Maeshima, Akiko Miyagi
    Makita, Shin-ichi
    Kitahara, Hideaki
    Miyamoto, Ken-ichi
    Fukuhara, Suguru
    Suzuki, Tatsuya
    Munakata, Wataru
    Kobayashi, Yukio
    Tajima, Kinuko
    Itami, Jun
    Taniguchi, Hirokazu
    Tobinai, Kensei
    BLOOD, 2014, 124 (21)
  • [50] MYC and BCL2 Gene Rearrangements in Comparison to MYC and BCL2 Protein Expression in AIDS-Related Diffuse Large B Cell Lymphomas
    Nam, Anna
    Mathew, Susan
    Liu, Yen-Chun
    Chadburn, Amy
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146
12345